HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linkage of Lambda Interferons in Protection Against Severe COVID-19.

Abstract
The most recently discovered interferon (IFN) family, type III IFNs or lambda IFNs (IFN-λs) are caused by viral infection and act in mucosal barriers, such as the respiratory tract. In this study, we assessed the serum levels of IFN-λs in new coronavirus disease-2019 (COVID-19) patients. Sixty-four COVID-19 patients were enrolled in this study. All cases were divided into the intensive care unit (ICU) and non-ICU groups according to their symptoms. Fourteen samples of healthy controls were also included. The serum levels of IFN-λ1 and IFN-λ2 were analyzed by specific enzyme-linked immunosorbent assay (ELISA) kits. The concentrations of IFN-λ1 and IFN-λ2 induced in the serum of non-ICU patients (836.7 ± 284.6 and 798.8 ± 301.5 pg/mL, respectively) were higher than found in ICU patients (81.57 ± 34.25 and 48.32 ± 28.13 pg/mL, respectively) (P = 0.004 and P = 0.006, respectively) and healthy controls (85.57 ± 33.63 and 65.82 ± 21.26 pg/mL, respectively) (P = 0.03 and P = 0.04, respectively). Meanwhile, no significant differences were found in the concentration of both cytokines between the ICU patients and healthy controls. We conclude that higher levels of IFN-λs are associated with decreased clinical manifestations in COVID-19 patients. These cytokines could be a promising therapeutic agent to avoid the overwhelming consequences of COVID-19.
AuthorsMehdi Shahbazi, Parviz Amri Maleh, Mojgan Bagherzadeh, Zahra Moulana, Mahdi Sepidarkish, Maryam Rezanejad, Mohammad Mirzakhani, Soheil Ebrahimpour, Hosein Ghorbani, Zahra Ahmadnia, Mostafa Javanian, Masomeh Bayani, Mousa Mohammadnia-Afrouzi
JournalJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research (J Interferon Cytokine Res) Vol. 41 Issue 4 Pg. 149-152 (04 2021) ISSN: 1557-7465 [Electronic] United States
PMID33885337 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • IFNL1 protein, human
  • IFNL2 protein, human
  • Interleukins
  • Interferons
Topics
  • Adult
  • Aged
  • COVID-19 (blood, prevention & control)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interferons (blood)
  • Interleukins (blood)
  • Male
  • Middle Aged
  • SARS-CoV-2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: